Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Medexus Pharmaceuticals Inc ( (TSE:MDP) ) is now available.
Medexus Pharmaceuticals Inc. announces an overnight marketed public offering of common shares, led by Raymond James Ltd. The proceeds will be used to repay a credit from medac, pay a milestone amount, and support working capital and corporate purposes. The offering is conducted via a prospectus supplement and may include private placement in the U.S., subject to regulatory approvals. This move is expected to enhance Medexus’s financial flexibility and support its business development initiatives.
More about Medexus Pharmaceuticals Inc
Medexus Pharmaceuticals is a leading specialty pharmaceutical company focused on North America, offering a range of innovative treatments for rare diseases. The company targets therapeutic areas like oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology.
YTD Price Performance: 42.61%
Average Trading Volume: 64,758
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$121.3M
Find detailed analytics on MDP stock on TipRanks’ Stock Analysis page.
